rcc 36 has been researched along with Urination Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, S; Ishibashi, S; Iwakura, K; Kikumori, M; Kouyama, H; Nishimori, T; Sumi, N; Taniguchi, Y | 1 |
| Iwakura, K; Kitayama, E; Sumi, N; Tamura, H; Watanabe, M; Yamashita, Y | 1 |
2 other study(ies) available for rcc 36 and Urination Disorders
| Article | Year |
|---|---|
[Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency a
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Male; Phenylacetates; Rats; Rats, Sprague-Dawley; Urinary Incontinence; Urination Disorders | 1997 |
[Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
Topics: Animals; Cells, Cultured; Cricetinae; Erythrocytes; Escherichia coli; Male; Mice; Molecular Structure; Mutagenicity Tests; Mutagens; Phenylacetates; Salmonella typhimurium; Urinary Incontinence; Urination Disorders | 1997 |